Catalogue
Download
Inquiry
BUSINESS AREA
R&D
PRODUCT
Cell therapy Aesthetics Pharmaceuticals Cosmetics
NEO NEWS
Announcement Newsletter Media Exhibition Academy & Seminar
INQUIRIES
Inquiry FAQ
GLOBAL NETWORK
Global Network
COMPANY
Brand Story Company History
BUSINESS AREA
PRODUCT
Cell therapy Aesthetics Pharmaceuticals Cosmetics
NEO NEWS
Announcement Newsletter Media Exhibition Academy & Seminar
INQUIRIES
Inquiry FAQ
GLOBAL NETWORK
COMPANY
Brand Story Company History
English
한국어 中文 العربية Pусский
NEO NEWS NeoGenesis Archives
Announcement
Newsletter
Media
Exhibition
Academy & Seminar
Media
Meet NeoGenesis in the media.

Neogenesis acquires CE certificate for filler 'Regenovue' containing l…

페이지 정보

上传者 NEOGENESIS 조회 875회 작성일 21-06-01 15:52

본문

80fb6e54155bc3cfe1f521496da97129_1622530083_85.PNG
80fb6e54155bc3cfe1f521496da97129_1622530084_74.PNG 

“Medical Today” in April 2021 published an article

that Neogenesis will receive CE certification for filler 'Regenovue' 

containing lidocaine.



http://www.mdtoday.co.kr/mdtoday/index.html?no=419300

Company Introduction Privacy Statement
COMPANY INFO
NeoGenesis Co., Ltd. CEO Yongpil Kim
Address #307, Think Factory Bldg. C, 150 Yeongdeungpo-ro, Yeongdeungpo-gu, Seoul, South Korea (07292)
Business Number 264-81-32217 Tel +82 2-583-1348
Fax +82 2-2038-0848 Email info@neogenesis.co.kr

Copyright ⓒ 2022 NeoGenesis Co., Ltd. All Rights Reserved.
CS CENTER
+82 2-583-1348 FAX : +82 2-2038-0848
- Operating Hours: 09:30~18:30 KST Weekdays / Closed on weekends & public holidays